Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP845360.RAv7usj_ibn_Hxh5ZO_IAf4BTgIyph-xFzAnNhWAGswpI130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP845360.RAv7usj_ibn_Hxh5ZO_IAf4BTgIyph-xFzAnNhWAGswpI130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP845360.RAv7usj_ibn_Hxh5ZO_IAf4BTgIyph-xFzAnNhWAGswpI130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP845360.RAv7usj_ibn_Hxh5ZO_IAf4BTgIyph-xFzAnNhWAGswpI130_provenance.
- NP845360.RAv7usj_ibn_Hxh5ZO_IAf4BTgIyph-xFzAnNhWAGswpI130_assertion description "[Microsatellites within the coding region of the transforming growth factor beta receptor type II (RII) and insulin-like growth factor II receptor (IGF-IIR) genes were reported to be targets for mutation during the course of carcinogenesis in MI+ tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP845360.RAv7usj_ibn_Hxh5ZO_IAf4BTgIyph-xFzAnNhWAGswpI130_provenance.
- NP845360.RAv7usj_ibn_Hxh5ZO_IAf4BTgIyph-xFzAnNhWAGswpI130_assertion evidence source_evidence_literature NP845360.RAv7usj_ibn_Hxh5ZO_IAf4BTgIyph-xFzAnNhWAGswpI130_provenance.
- NP845360.RAv7usj_ibn_Hxh5ZO_IAf4BTgIyph-xFzAnNhWAGswpI130_assertion SIO_000772 9563904 NP845360.RAv7usj_ibn_Hxh5ZO_IAf4BTgIyph-xFzAnNhWAGswpI130_provenance.
- NP845360.RAv7usj_ibn_Hxh5ZO_IAf4BTgIyph-xFzAnNhWAGswpI130_assertion wasDerivedFrom befree-20140225 NP845360.RAv7usj_ibn_Hxh5ZO_IAf4BTgIyph-xFzAnNhWAGswpI130_provenance.
- NP845360.RAv7usj_ibn_Hxh5ZO_IAf4BTgIyph-xFzAnNhWAGswpI130_assertion wasGeneratedBy ECO_0000203 NP845360.RAv7usj_ibn_Hxh5ZO_IAf4BTgIyph-xFzAnNhWAGswpI130_provenance.
- befree-20140225 importedOn "2014-02-25" NP845360.RAv7usj_ibn_Hxh5ZO_IAf4BTgIyph-xFzAnNhWAGswpI130_provenance.